Comparison of the Effects of the Direct Thrombin Inhibitor, Pradaxa, to That of Warfarin on Bone Mass and Bone Turnover Markers
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 24 Mar 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Mar 2017.
- 24 Mar 2017 Status changed from recruiting to discontinued due to low enrollment numbers.